You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
24 August 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-B) said on Monday it has received European Commission orphan designation for asedebart (Lu AG13909), its investigational anti-ACTH monoclonal antibody for Cushing's syn...
24 August 2026 - South Korean pharmaceutical company Hanmi Pharm Co Ltd announced on Monday that it has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), for the development, manu...
24 August 2026 - Medical technology company Pulnovo Medical announced on Sunday the enrolment of the first two patients in its PULSE-LHD clinical trial, conducted under a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE), a...
24 August 2026 - Anbogen Therapeutics Inc (TPEx:7784), a Taiwan-based, clinical-stage precision oncology company, announced on Sunday that it has entered into a Collaborative Research Agreement (CRA) with the Laboratory of Veterinary Surgery, Graduat...
24 August 2026 - Chinese pharmaceutical company CureGene announced on Friday that the first subject has been dosed in its Phase I clinical trial of CG-0416, a novel oral liver-targeting THR-beta agonist developed in-house, in Australia.The company sa...
21 August 2026 - Genetic Analysis AS (Spotlight Stock Market: GEAN), a Norwegian microbiome diagnostics company, on Friday announced the launch of its technology at the Centre for Digestive Diseases in Sydney, a specialist gastroenterology centre off...
21 August 2026 - China-based biotechnology company Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) said on Friday that the Centre for Drug Evaluation of the National Medical Products Administration has accepted its New Drug Application for Opamtistomig (...